First Trust Advisors
LEGN icon

First Trust Advisors’s Legend Biotech LEGN Stock Holding History

First Trust Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,208
Closed -$659K – 2677
2025
Q3 		$659K Buy
20,208
+8,621
+74% +$318K ﹤0.01% 2246
2025
Q2 		$411K Buy
+11,587
New +$375K ﹤0.01% 2329
2025
Q1 		– Sell
-20,669
Closed -$673K – 2588
2024
Q4 		$673K Buy
20,669
+8,948
+76% +$371K ﹤0.01% 2160
2024
Q3 		$571K Buy
+11,721
New +$624K ﹤0.01% 2144
2024
Q2 		– Sell
-44,653
Closed -$2.5M – 2379
2024
Q1 		$2.5M Buy
44,653
+20,845
+88% +$1.26M ﹤0.01% 1636
2023
Q4 		$1.43M Sell
23,808
-30,351
-56% -$1.92M ﹤0.01% 1860
2023
Q3 		$3.64M Buy
54,159
+5,470
+11% +$380K ﹤0.01% 1398
2023
Q2 		$3.36M Sell
48,689
-52,771
-52% -$3.45M ﹤0.01% 1439
2023
Q1 		$4.89M Sell
101,460
-225,191
-69% -$11M 0.01% 1235
2022
Q4 		$16.3M Buy
326,651
+76,315
+30% +$3.7M 0.02% 798
2022
Q3 		$10.2M Buy
250,336
+172,980
+224% +$8.12M 0.01% 943
2022
Q2 		$4.25M Sell
77,356
-1,486
-2% -$62.8K 0.01% 1318
2022
Q1 		$2.87M Sell
78,842
-26,351
-25% -$1.04M ﹤0.01% 1626
2021
Q4 		$4.9M Buy
+105,193
New +$5.34M ﹤0.01% 1374

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

First Trust Advisors's LEGN Position: Q4 2025 in Review

First Trust Advisors sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 20,208 shares — an estimated $659K sold.

First Trust Advisors first reported a position in LEGN in Q4 2021 and held it in 14 quarters. The position peaked at $16.3M in Q4 2022. 200 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • First Trust Advisors reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
  • First Trust Advisors sold 20,208 Legend Biotech shares in Q4 2025, an estimated $659K.
  • First Trust Advisors first reported a position in Legend Biotech in Q4 2021 and held it in 14 quarters.
  • First Trust Advisors's Legend Biotech position peaked at $16.3M in Q4 2022.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on First Trust Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.